Differential effects of milnacipran and fluvoxamine, especially in patients with severe depression and agitated depression: A case-control study

International Clinical Psychopharmacology

Volumn 17, Issue 2, 2002, Pages 53-58

  Fukuchi, T ^a   Kanemoto, Kousuke ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Agitated depression; Fluvoxamine; Milnacipran; Severe depression

Indexed keywords

FLUVOXAMINE; MILNACIPRAN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGITATION; ANXIETY; ARTICLE; CASE CONTROL STUDY; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG WITHDRAWAL; FATIGUE; FEMALE; GASTROINTESTINAL TOXICITY; HEART PALPITATION; HOT FLUSH; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORTHOSTATIC HYPOTENSION; OUTPATIENT; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SOMNOLENCE; TREATMENT OUTCOME; TREMOR; URINARY TRACT DISEASE; VERTIGO; XEROSTOMIA;

EID: 0036183825     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200203000-00002     Document Type: Article

References (26)

1. SSRI versus TCAs in depressed inpatients: A meta-analysis of efficacy and tolerability
2. Controlled comparison of milnacipran and fluoxetine in major depression
3. Fluoxetine and desipramine in major depressive disorder
4. The clinical efficacy of venlafaxine in the treatment of depression
5. Antidepressant efficacy and tolerability of milnacipran, a dual serotonin and noradrenaline reuptake inhibitor: A comparison with fluvoxamine
6. Therapeutic contribution of milnacipran and of clomipramine during a 3-month treatment: Results of a comparative study
7. A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia
8. Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients
9. The drug treatment of anxiety and depression
10. Citalopram: Clinical effect profile in comparison with clomipramine. A controlled multicentre study
11. Paroxetine: A selective serotonin reuptake inhibitor showing bettwe tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study
12. Comparison of the cost-effectiveness of milnacipran (a SNRI) with TCAs and SSRIs: A modeling approach
13. SSRIs in anxious-agitated depression: A post-hoc analysis of 279 patients
14. A double-blind comparison of the efficacy and safety of milnacipran and fluoxetine in depressed patients
15. Comparative studies with milnacipran and TCAs in the treatment of patients with major depression: A summary of clinical trial results
16. Clinical efficacy of milnacipran. Placebo-controlled trials
17. Milnacipran and selective serotonin reuptake inhibitors in major depression
18. The efficacy of fluoxemine in patients with severe depression
19. Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: An overview of its antidepressant activity and clinical tolerability
20. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclic in the treatment of melancholia
21. Milnacipran efficacy in the prevention of recurrent depression: A 12-month placebo-controlled study
22. Milnacipran. A review of its use in depression
23. A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients
24. Depressive mania versus agitated depression: Biogenic amine and hypothalamic-pituitary-adrenocortical function
25. LY 248686, a new inhibitor of serotonin and norepinephrine uptake
26. The different versions of the Hamilton Depression Rating Scale